Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas De Raedt

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Pediatric Neurosurgery|February 6, 2023
Updates in the Management of Central and Peripheral Nervous System Tumors among Patients with Neurofibromatosis Type 1 and Neurofibromatosis Type 2Chelsea Kotch, Stephanie Nicole Brosius, Thomas De Raedt, et al.
Journal of Visualized Experiments : Jove|February 19, 2024
Spheroid Drug Sensitivity Screening in Glioma Stem Cell LinesKyra Harvey, Katherine Labella, Angela Liou, et al.
Plos One|February 2, 2023
Identification of therapeutic sensitivities in a spheroid drug combination screen of Neurofibromatosis Type I associated High Grade GliomasJacquelyn Dougherty, Kyra Harvey, Angela Liou, et al.
Genomics|July 6, 2004
Genomic organization and evolution of the NF1 microdeletion regionThomas De Raedt, Hilde Brems, Catalina Lopez-Correa, et al.
Pediatric Blood & Cancer|August 4, 2005
Therapy-related acute myeloid leukemia in a child with Noonan syndrome and clonal duplication of the germline PTPN11 mutationChristophe F Chantrain, Priscilla Jijon, Thomas De Raedt, et al.
European Journal of Human Genetics : EJHG|January 24, 2008
Copy number variations in the NF1 gene region are infrequent and do not predispose to recurrent type-1 deletionsKatharina Steinmann, Lan Kluwe, David N Cooper, et al.
Gastroenterology|November 8, 2006
Intestinal neurofibromatosis is a subtype of familial GIST and results from a dominant activating mutation in PDGFRAThomas de Raedt, Jan Cools, Maria Debiec-Rychter, et al.
Cancer Cell|September 14, 2013
The RasGAP gene, RASAL2, is a tumor and metastasis suppressorSara Koenig McLaughlin, Sarah Naomi Olsen, Benjamin Dake, et al.
Iscience|July 27, 2020
Imaging Mass Spectrometry Reveals Tumor Metabolic HeterogeneityYang Zhang, Christelle Guillermier, Thomas De Raedt, et al.
Human Mutation|August 31, 2006
Comprehensive NF1 screening on cultured Schwann cells from neurofibromasOphélia Maertens, Hilde Brems, Jo Vandesompele, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Pediatric Neurosurgery|February 6, 2023
Updates in the Management of Central and Peripheral Nervous System Tumors among Patients with Neurofibromatosis Type 1 and Neurofibromatosis Type 2Chelsea Kotch, Stephanie Nicole Brosius, Thomas De Raedt, et al.
Journal of Visualized Experiments : Jove|February 19, 2024
Spheroid Drug Sensitivity Screening in Glioma Stem Cell LinesKyra Harvey, Katherine Labella, Angela Liou, et al.
Plos One|February 2, 2023
Identification of therapeutic sensitivities in a spheroid drug combination screen of Neurofibromatosis Type I associated High Grade GliomasJacquelyn Dougherty, Kyra Harvey, Angela Liou, et al.
Genomics|July 6, 2004
Genomic organization and evolution of the NF1 microdeletion regionThomas De Raedt, Hilde Brems, Catalina Lopez-Correa, et al.
Pediatric Blood & Cancer|August 4, 2005
Therapy-related acute myeloid leukemia in a child with Noonan syndrome and clonal duplication of the germline PTPN11 mutationChristophe F Chantrain, Priscilla Jijon, Thomas De Raedt, et al.
European Journal of Human Genetics : EJHG|January 24, 2008
Copy number variations in the NF1 gene region are infrequent and do not predispose to recurrent type-1 deletionsKatharina Steinmann, Lan Kluwe, David N Cooper, et al.
Gastroenterology|November 8, 2006
Intestinal neurofibromatosis is a subtype of familial GIST and results from a dominant activating mutation in PDGFRAThomas de Raedt, Jan Cools, Maria Debiec-Rychter, et al.
Cancer Cell|September 14, 2013
The RasGAP gene, RASAL2, is a tumor and metastasis suppressorSara Koenig McLaughlin, Sarah Naomi Olsen, Benjamin Dake, et al.
Iscience|July 27, 2020
Imaging Mass Spectrometry Reveals Tumor Metabolic HeterogeneityYang Zhang, Christelle Guillermier, Thomas De Raedt, et al.
Human Mutation|August 31, 2006
Comprehensive NF1 screening on cultured Schwann cells from neurofibromasOphélia Maertens, Hilde Brems, Jo Vandesompele, et al.
Pageof 4